Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia
Journal of Clinical Oncology, 2011, 29(12): 1634-1642.
Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia
Journal of Clinical Oncology, 2011, 29(12): 1634-1642.
测试 · 1